Literature DB >> 28390697

Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.

.   

Abstract

BACKGROUND: The scale-up of tobacco control, especially after the adoption of the Framework Convention for Tobacco Control, is a major public health success story. Nonetheless, smoking remains a leading risk for early death and disability worldwide, and therefore continues to require sustained political commitment. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) offers a robust platform through which global, regional, and national progress toward achieving smoking-related targets can be assessed.
METHODS: We synthesised 2818 data sources with spatiotemporal Gaussian process regression and produced estimates of daily smoking prevalence by sex, age group, and year for 195 countries and territories from 1990 to 2015. We analysed 38 risk-outcome pairs to generate estimates of smoking-attributable mortality and disease burden, as measured by disability-adjusted life-years (DALYs). We then performed a cohort analysis of smoking prevalence by birth-year cohort to better understand temporal age patterns in smoking. We also did a decomposition analysis, in which we parsed out changes in all-cause smoking-attributable DALYs due to changes in population growth, population ageing, smoking prevalence, and risk-deleted DALY rates. Finally, we explored results by level of development using the Socio-demographic Index (SDI).
FINDINGS: Worldwide, the age-standardised prevalence of daily smoking was 25·0% (95% uncertainty interval [UI] 24·2-25·7) for men and 5·4% (5·1-5·7) for women, representing 28·4% (25·8-31·1) and 34·4% (29·4-38·6) reductions, respectively, since 1990. A greater percentage of countries and territories achieved significant annualised rates of decline in smoking prevalence from 1990 to 2005 than in between 2005 and 2015; however, only four countries had significant annualised increases in smoking prevalence between 2005 and 2015 (Congo [Brazzaville] and Azerbaijan for men and Kuwait and Timor-Leste for women). In 2015, 11·5% of global deaths (6·4 million [95% UI 5·7-7·0 million]) were attributable to smoking worldwide, of which 52·2% took place in four countries (China, India, the USA, and Russia). Smoking was ranked among the five leading risk factors by DALYs in 109 countries and territories in 2015, rising from 88 geographies in 1990. In terms of birth cohorts, male smoking prevalence followed similar age patterns across levels of SDI, whereas much more heterogeneity was found in age patterns for female smokers by level of development. While smoking prevalence and risk-deleted DALY rates mostly decreased by sex and SDI quintile, population growth, population ageing, or a combination of both, drove rises in overall smoking-attributable DALYs in low-SDI to middle-SDI geographies between 2005 and 2015.
INTERPRETATION: The pace of progress in reducing smoking prevalence has been heterogeneous across geographies, development status, and sex, and as highlighted by more recent trends, maintaining past rates of decline should not be taken for granted, especially in women and in low-SDI to middle-SDI countries. Beyond the effect of the tobacco industry and societal mores, a crucial challenge facing tobacco control initiatives is that demographic forces are poised to heighten smoking's global toll, unless progress in preventing initiation and promoting cessation can be substantially accelerated. Greater success in tobacco control is possible but requires effective, comprehensive, and adequately implemented and enforced policies, which might in turn require global and national levels of political commitment beyond what has been achieved during the past 25 years. FUNDING: Bill & Melinda Gates Foundation and Bloomberg Philanthropies.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28390697      PMCID: PMC5439023          DOI: 10.1016/S0140-6736(17)30819-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  55 in total

1.  The tobacco industry tactics-a challenge for tobacco control in low and middle income countries.

Authors:  D Doku
Journal:  Afr Health Sci       Date:  2010-06       Impact factor: 0.927

2.  Deaths and taxes: stronger global tobacco control by 2025.

Authors:  Prabhat Jha
Journal:  Lancet       Date:  2015-03-14       Impact factor: 79.321

3.  Outcomes for a Public Hospital Tobacco Cessation Program: The Cook County Health and Hospitals System Experience.

Authors:  David N Goldberg; Anne J Krantz; Sara Semal; Huiyuan Zhang; William E Trick
Journal:  J Community Health       Date:  2016-12

4.  FCTC followed by accelerated implementation of tobacco advertising bans.

Authors:  Heikki Hiilamo; Stanton Glantz
Journal:  Tob Control       Date:  2016-07-28       Impact factor: 7.552

Review 5.  Implementation and research priorities for FCTC Articles 13 and 16: tobacco advertising, promotion, and sponsorship and sales to and by minors.

Authors:  Rebekah H Nagler; Kasisomayajula Viswanath
Journal:  Nicotine Tob Res       Date:  2013-01-04       Impact factor: 4.244

Review 6.  Moving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union-part I: establishing cigarette imports.

Authors:  A B Gilmore; M McKee
Journal:  Tob Control       Date:  2004-06       Impact factor: 7.552

7.  Global effects of smoking, of quitting, and of taxing tobacco.

Authors:  Prabhat Jha; Richard Peto
Journal:  N Engl J Med       Date:  2014-01-02       Impact factor: 91.245

Review 8.  Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement.

Authors:  Gretchen A Stevens; Leontine Alkema; Robert E Black; J Ties Boerma; Gary S Collins; Majid Ezzati; John T Grove; Daniel R Hogan; Margaret C Hogan; Richard Horton; Joy E Lawn; Ana Marušić; Colin D Mathers; Christopher J L Murray; Igor Rudan; Joshua A Salomon; Paul J Simpson; Theo Vos; Vivian Welch
Journal:  Lancet       Date:  2016-06-28       Impact factor: 79.321

9.  Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study.

Authors:  Vasilis Kontis; Colin D Mathers; Jürgen Rehm; Gretchen A Stevens; Kevin D Shield; Ruth Bonita; Leanne M Riley; Vladimir Poznyak; Robert Beaglehole; Majid Ezzati
Journal:  Lancet       Date:  2014-05-02       Impact factor: 79.321

10.  Impact of smoking reduction on coronary heart disease mortality trends during 1981-2000 in England and Wales.

Authors:  B Unal; Ja Critchley; S Capewell
Journal:  Tob Induc Dis       Date:  2003-09-15       Impact factor: 2.600

View more
  447 in total

Review 1.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

2.  Cigarette Use Among Individuals with Alcohol Use Disorders in the United States, 2002 to 2016: Trends Overall and by Race/Ethnicity.

Authors:  Andrea H Weinberger; Lauren R Pacek; Daniel Giovenco; Sandro Galea; Michael J Zvolensky; Misato Gbedemah; Renee D Goodwin
Journal:  Alcohol Clin Exp Res       Date:  2018-12-10       Impact factor: 3.455

3.  A Comparison of Smoking History in the Electronic Health Record With Self-Report.

Authors:  Nikhil Patel; David P Miller; Anna C Snavely; Christina Bellinger; Kristie L Foley; Doug Case; Malcolm L McDonald; Youssef R Masmoudi; Ajay Dharod
Journal:  Am J Prev Med       Date:  2020-01-23       Impact factor: 5.043

Review 4.  Environmental exposures and mechanisms in allergy and asthma development.

Authors:  Liza Bronner Murrison; Eric B Brandt; Jocelyn Biagini Myers; Gurjit K Khurana Hershey
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

5.  Will the Swiss pavilion at Expo 2020 Dubai damage your health?

Authors:  Nino Künzli; Milo A Puhan; L Suzanne Suggs
Journal:  Int J Public Health       Date:  2019-07-30       Impact factor: 3.380

6.  Relationship between religiosity and smoking among undergraduate health sciences students.

Authors:  Edson Zangiacomi Martinez; Carolina Cunha Bueno-Silva; Isabela Mirandola Bartolomeu; Livia Borges Ribeiro-Pizzo; Miriane Lucindo Zucoloto
Journal:  Trends Psychiatry Psychother       Date:  2021-01-22

Review 7.  Surviving With Smog and Smoke: Precision Interventions?

Authors:  Hua Cai; Chen Wang
Journal:  Chest       Date:  2017-07-08       Impact factor: 9.410

8.  The top-down regulation from the prefrontal cortex to insula via hypnotic aversion suggestions reduces smoking craving.

Authors:  Xiaoming Li; Lijun Chen; Ru Ma; Haibao Wang; Li Wan; Ying Wang; Junjie Bu; Wei Hong; Wanwan Lv; Sabine Vollstädt-Klein; Yihong Yang; Xiaochu Zhang
Journal:  Hum Brain Mapp       Date:  2018-11-22       Impact factor: 5.038

Review 9.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

Review 10.  Glial cells as therapeutic targets for smoking cessation.

Authors:  Mohit Kumar; Adewale Adeluyi; Erin L Anderson; Jill R Turner
Journal:  Neuropharmacology       Date:  2020-05-24       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.